Related Experiment Videos
Inhibition of bacterial growth by the nitrofurantoin solvent dimethylformamide
Antimicrobial Agents and Chemotherapy
|March 1, 1976
Abstract:
For quantitative susceptibility tests, stock solutions of nitrofurantoin are often prepared in dimethylformamide. Since 1.0 or 2.0 ml of the solvent will inhibit microbial growth, currently recommended procedures for antimicrobic dilution tests should be modified by adding only 0.1 or 0.2 ml of stock drug solutions to the agar or broth medium.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
The Journal of antimicrobial chemotherapy·2009
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods.
Antimicrobial agents and chemotherapy·2002
Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.
Journal of clinical microbiology·2001
Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media.
The Journal of antimicrobial chemotherapy·2001
Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2001
In vitro activity of the ketolide ABT-773.
Antimicrobial agents and chemotherapy·2001
Anti-plasmodial activity of proteasome inhibitors against various Plasmodium species: a preclinical evaluation.
Antimicrobial agents and chemotherapy·2026
Pharmacokinetics, safety, and tolerability of ceftibuten-ledaborbactam etzadroxil in participants with renal impairment.
Antimicrobial agents and chemotherapy·2026
Inhibition of type II NADH dehydrogenase in Mycobacterium tuberculosis reveals collateral vulnerability in the electron transport chain.
Antimicrobial agents and chemotherapy·2026
In vitro activity of zosurabalpin against a global set of carbapenem-resistant-A. baumannii clinical isolates.
Antimicrobial agents and chemotherapy·2026
A framework of Microbial Genomic Database for clinical metagenomic pathogen diagnosis: development and multi-cohort evaluation.
Frontiers in cellular and infection microbiology·2026
Culture Positivity Reflects Quantitative Bacterial Bioburden in Open Fractures.
bioRxiv : the preprint server for biology·2026
Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a case-control study.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Post-Microbial Therapeutics for the Next Generation of Medicine.
MicrobiologyOpen·2026
Aseptic Meningitis Unmasking Coccidioidomycosis of the Central Nervous System Outside an Endemic Region.
Internal medicine (Tokyo, Japan)·2026